Skip to main content

Table 1 Characteristics of PLHIV who were screened for tuberculosis and cryptococcal meningitis while they were admitted to the medical wards at KCH, Lilongwe, Malawi, 2016–2017

From: Implementation of tuberculosis and cryptococcal meningitis rapid diagnostic tests amongst patients with advanced HIV at Kamuzu Central Hospital, Malawi, 2016–2017

Characteristic Total
N (%)
HIV diagnosis on admission P-value*
Old diagnosis
N (%)
New diagnosis
N (%)
Unknown*
N (%)
Gender      
 Female 205 (47.8) 164 (50.2) 24 (32.9) 17 (58.6) 0.01
 Male 224 (52.2) 163 (49.8) 49 (67.1) 12 (41.4)  
Age (years)      
 14–20 15 (3.8) 11 (3.6) 4 (5.7) 0 (0.0)  
 21–30 87 (21.7) 65 (21.1) 16 (22.9) 6 (27.3)  
 31–40 163 (40.8) 124 (40.3) 29 (41.4) 10 (45.4) 0.92
 41–50 85 (21.2) 67 (21.7) 13 (18.6) 5 (22.7)  
 50 +  50 (12.5) 41 (13.3) 8 (11.4) 1 (4.6)  
BMI      
 < 18.5 80 (27.7) 64 (28.2) 13 (27.1) 3 (21.4)  
 18.5–24.9 185 (64.0) 141 (62.1) 33 (68.7) 11 (78.6) 0.79
 25.0–29.9 18 (6.2) 17 (7.5) 1 (2.1) 0 (0.0)  
 30 +  3 (2.1) 5 (2.2) 1 (2.1) 0 (0.0)  
CD4 count      
 ≤ 100 cells/mm3 152 (41.5) 119 (41.9) 20 (32.3) 12 (63.2)  
 101–200 cells/mm3 69 (18.9) 46 (16.2) 20 (32.3) 3 (15.8) 0.02
 ≥ 200 cells/mm3 145 (39.6) 119 (41.9) 22 (35.4) 4 (21.0)  
WHO clinical stage
 Stage 1 42 (12.5) 30 (11.4) 11 (19.6) 1 (6.7)  
 Stage 2 11 (3.3) 10 (3.8) 1 (1.8) 0 (0) 0.08
 Stage 3 215 (64.0) 164 (62.1) 40 (71.4) 10 (66.7)  
 Stage 4 68 (20.2) 60 (22.7) 4 (7.2) 4 (26.6)  
  1. 9 missing gender, 38 missing age, 149 missing BMI, 9 missing gender, 73 missing CD4 cell count, and 103 missing WHO clinical stage
  2. *Fisher’s exact test